Recommended Topic Related To:

Voltaren Ophthalmic

"The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter "...

Voltaren Ophthalmic

Voltaren Ophthalmic Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Voltaren Ophthalmic (diclofenac sodium) Solution 0.1% is used to reduce swelling, pain, and light sensitivity after cataract surgery or corneal refractive surgery. It is a nonsteroidal anti-inflammatory drug (NSAID). This medication is available in generic form. Common side effects include stinging/burning of the eyes for 1 to 2 minutes and temporary blurred vision this medication is applied. Watery eyes may also occur.

A dose of one drop of Voltaren Ophthalmic should be applied to the affected eye following cataract surgery, 4 times daily beginning 24 hours after surgery and continuing throughout the first 2 weeks of the postoperative period. One or two drops of Voltaren Ophthalmic should be applied to the operative eye within the hour prior to corneal refractive surgery. Within 15 minutes after surgery, one or two drops should be applied to the operative eye and continued 4 times daily for up to 3 days. Voltaren Ophthalmic may interact with blood thinners. Tell your doctor all medications and supplements you use. During pregnancy, Voltaren Ophthalmic should be used only when clearly needed during the first 6 months. It is not recommended for use during the last 3 months of pregnancy due to possible harm to a fetus. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Our Voltaren Ophthalmic (diclofenac sodium) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Patient Information in Detail?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Voltaren Ophthalmic in Detail - Patient Information: Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have a serious side effect such as:

  • severe burning, stinging, or itching of your eyes;
  • eye pain, redness, or excessive watering;
  • vision changes, increased sensitivity to light;
  • white patches on your eyes;
  • crusting or drainage of your eyes; or
  • dizziness, stomach pain, vomiting, weakness, fever, chills, or flu symptoms (can occur if the medicine is absorbed into your bloodstream).

Less serious side effects may include:

  • mild burning, stinging, or itching of your eyes;
  • swollen or puffy eyelids;
  • nausea, vomiting, stomach pain;
  • weakness, fever or chills;
  • headache;
  • sleep problems (insomnia); or
  • runny nose.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Voltaren Ophthalmic (Diclofenac Sodium Ophthalmic Solution) »

What is Patient Information Overview?

A concise overview of the drug for the patient or caregiver from First DataBank.

Voltaren Ophthalmic Overview - Patient Information: Side Effects

SIDE EFFECTS: Stinging/burning of the eyes for 1 to 2 minutes and temporary blurred vision may occur when you apply this medication. Watery eyes may also occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

Tell your doctor immediately if any of these rare but serious side effects occur: eye pain, decreased vision, bleeding in the eye (increased redness in the eye).

A very serious allergic reaction to this drug is rare. However, seek immediate medical attention if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

In the US -

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

Read the entire patient information overview for Voltaren Ophthalmic (Diclofenac Sodium Ophthalmic Solution)»

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Voltaren Ophthalmic FDA Prescribing Information: Side Effects
(Adverse Reactions)

SIDE EFFECTS

Ocular

Transient burning and stinging were reported in approximately 15% of patients across studies with the use of Voltaren Ophthalmic. In cataract surgery studies, keratitis was reported in up to 28% of patients receiving Voltaren Ophthalmic, although in many of these cases keratitis was initially noted prior to the initiation of treatment. Elevated intraocular pressure following cataract surgery was reported in approximately 15% of patients undergoing cataract surgery. Lacrimation complaints were reported in approximately 30% of case studies undergoing incisional refractive surgery. The following adverse reactions were reported in approximately 10% or less of the patients: abnormal vision, acute elevated IOP, blurred vision, conjunctivitis, corneal deposits, corneal edema, corneal opacity, corneal lesions, discharge, eyelid swelling, eye pain, injection (redness), iritis, irritation, itching, lacrimation disorder, and ocular allergy.

Systemic

The following adverse reactions were reported in 3% or less of the patients: abdominal pain, asthenia, chills, dizziness, facial edema, fever, headache, insomnia, nausea, pain, rhinitis, viral infection, and vomiting.

Clinical Practice

The following reactions have been identified during postmarketing use of topical diclofenac sodium ophthalmic solution, 0.1% in clinical practice. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. The reactions, which have been chosen for inclusion due to either their seriousness, frequency of reporting, possible causal connection to topical diclofenac sodium ophthalmic solution, 0.1%, or a combination of these factors, include corneal erosion, corneal infiltrates, corneal perforation, corneal thinning, corneal ulceration, and epithelial breakdown (see PRECAUTIONS, General).

Read the entire FDA prescribing information for Voltaren Ophthalmic (Diclofenac Sodium Ophthalmic Solution) »

A A A

Voltaren Ophthalmic - User Reviews

Voltaren Ophthalmic User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Voltaren Ophthalmic sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.


NIH talks about Ebola on WebMD